While the cancer-related roles of TOX are still not fully understood, recent studies have shown that TOX expression or mutations are deregulated in several diseases, particularly in malignancies like lung, breast, and gastric cancers, as well as lymphomas and leukemia. This evidence concerns the gene TOX and leukemia.